(-)-epigallocatechin 3-gallate increases expression ISO ADAMTS5 (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of ADAMTS5 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ADAMTS5 mRNA CTD PMID:22079256 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,2-dichloroethane decreases expression ISO Adamts5 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of ADAMTS5 mRNA CTD PMID:28189721 and PMID:28960355 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS5 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS5 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Adamts5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ADAMTS5 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Adamts5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ADAMTS5 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Adamts5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADAMTS5 mRNA CTD PMID:19465110 and PMID:33956508 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-amino-2-deoxy-D-glucopyranose decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Glucosamine analog results in decreased expression of ADAMTS5 mRNA CTD PMID:16300972 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 Glucosamine results in decreased cleavage of and results in decreased activity of ADAMTS5 protein alternative form CTD PMID:19909832 2-palmitoylglycerol increases expression ISO ADAMTS5 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of ADAMTS5 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Adamts5 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of ADAMTS5 mRNA CTD PMID:25172293 4,4'-sulfonyldiphenol increases expression ISO Adamts5 (Mus musculus) 6480464 bisphenol S results in increased expression of ADAMTS5 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO Adamts5 (Mus musculus) 6480464 Fenretinide results in decreased expression of ADAMTS5 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ADAMTS5 mRNA CTD PMID:24780913 acrylamide decreases expression ISO Adamts5 (Mus musculus) 6480464 Acrylamide results in decreased expression of ADAMTS5 mRNA CTD PMID:30807115 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ADAMTS5 mRNA CTD PMID:23630614 aldehydo-D-glucosamine decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Glucosamine analog results in decreased expression of ADAMTS5 mRNA CTD PMID:16300972 aldehydo-D-glucosamine multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 Glucosamine results in decreased cleavage of and results in decreased activity of ADAMTS5 protein alternative form CTD PMID:19909832 aldehydo-D-mannosamine decreases cleavage ISO ADAMTS5 (Homo sapiens) 6480464 mannosamine results in decreased cleavage of ADAMTS5 protein alternative form CTD PMID:19909832 all-trans-retinoic acid increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Tretinoin results in increased expression of ADAMTS5 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO Adamts5 (Mus musculus) 6480464 Tretinoin results in decreased expression of ADAMTS5 mRNA CTD PMID:36189433 all-trans-retinoic acid multiple interactions ISO Adamts5 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ADAMTS5 mRNA and [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ADAMTS5 mRNA CTD PMID:30951980 and PMID:36189433 Ammothamnine multiple interactions ISO Adamts5 (Mus musculus) 6480464 oxymatrine inhibits the reaction [IL1B protein results in increased expression of ADAMTS5 protein] CTD PMID:37196756 aristolochic acid A decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ADAMTS5 mRNA CTD PMID:33212167 arsane affects methylation ISO ADAMTS5 (Homo sapiens) 6480464 Arsenic affects the methylation of ADAMTS5 gene CTD PMID:25304211 arsenic atom affects methylation ISO ADAMTS5 (Homo sapiens) 6480464 Arsenic affects the methylation of ADAMTS5 gene CTD PMID:25304211 arsenous acid decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ADAMTS5 mRNA CTD PMID:25258189 benzo[a]pyrene decreases methylation ISO ADAMTS5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of ADAMTS5 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO ADAMTS5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ADAMTS5 exon CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO ADAMTS5 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 beta-D-glucosamine decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Glucosamine analog results in decreased expression of ADAMTS5 mRNA CTD PMID:16300972 beta-D-glucosamine multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 Glucosamine results in decreased cleavage of and results in decreased activity of ADAMTS5 protein alternative form CTD PMID:19909832 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ADAMTS5 mRNA and bisphenol A results in decreased expression of ADAMTS5 protein CTD PMID:25181051 and PMID:28285737 bisphenol A multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ADAMTS5 gene CTD PMID:31601247 bisphenol A affects methylation ISO ADAMTS5 (Homo sapiens) 6480464 bisphenol A affects the methylation of ADAMTS5 gene CTD PMID:31601247 bisphenol A increases expression ISO Adamts5 (Mus musculus) 6480464 bisphenol A results in increased expression of ADAMTS5 mRNA CTD PMID:30951980 bisphenol A multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of ADAMTS5 protein] CTD PMID:28285737 bisphenol F increases expression ISO Adamts5 (Mus musculus) 6480464 bisphenol F results in increased expression of ADAMTS5 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of ADAMTS5 gene CTD PMID:31601247 bisphenol F multiple interactions ISO Adamts5 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ADAMTS5 mRNA CTD PMID:30951980 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ADAMTS5 mRNA CTD PMID:33453195 caffeine increases expression EXP 6480464 Caffeine results in increased expression of ADAMTS5 mRNA CTD PMID:31874197 carbamazepine affects expression ISO ADAMTS5 (Homo sapiens) 6480464 Carbamazepine affects the expression of ADAMTS5 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Adamts5 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of ADAMTS5 mRNA CTD PMID:25554681 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of ADAMTS5 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO Adamts5 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of ADAMTS5 mRNA CTD PMID:37019170 chromium atom increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Chromium results in increased expression of ADAMTS5 mRNA CTD PMID:21437242 chromium(6+) affects expression ISO ADAMTS5 (Homo sapiens) 6480464 chromium hexavalent ion affects the expression of ADAMTS5 mRNA CTD PMID:30690063 cisplatin multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of ADAMTS5 mRNA CTD PMID:20705681 crocidolite asbestos increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of ADAMTS5 mRNA CTD PMID:24160326 dapagliflozin multiple interactions EXP 6480464 [SRT1460 co-treated with dapagliflozin] inhibits the reaction [IL1B protein results in increased expression of ADAMTS5 protein] and dapagliflozin inhibits the reaction [IL1B protein results in increased expression of ADAMTS5 protein] CTD PMID:37741535 DDT decreases expression EXP 6480464 DDT results in decreased expression of ADAMTS5 mRNA CTD PMID:30207508 dextran sulfate multiple interactions ISO Adamts5 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS5 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ADAMTS5 mRNA CTD PMID:25258189 diquat decreases expression ISO Adamts5 (Mus musculus) 6480464 Diquat results in decreased expression of ADAMTS5 mRNA CTD PMID:36851058 disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [bisphenol A results in decreased expression of ADAMTS5 protein] CTD PMID:28285737 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ADAMTS5 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS5 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ADAMTS5 mRNA CTD PMID:16404146 elemental selenium decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Selenium results in decreased expression of ADAMTS5 mRNA CTD PMID:19244175 ethanol multiple interactions ISO Adamts5 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ADAMTS5 mRNA CTD PMID:30517762 fenamidone increases expression ISO Adamts5 (Mus musculus) 6480464 fenamidone results in increased expression of ADAMTS5 mRNA CTD PMID:27029645 fluoranthene multiple interactions ISO Adamts5 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ADAMTS5 mRNA CTD PMID:28329830 fonofos increases methylation ISO ADAMTS5 (Homo sapiens) 6480464 Fonofos results in increased methylation of ADAMTS5 promoter CTD PMID:22847954 formaldehyde increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of ADAMTS5 mRNA CTD PMID:28937961 fulvestrant multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ADAMTS5 gene and [bisphenol F co-treated with Fulvestrant] results in decreased methylation of ADAMTS5 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of ADAMTS5 mRNA CTD PMID:27387713 GW 4064 decreases expression ISO Adamts5 (Mus musculus) 6480464 GW 4064 results in decreased expression of ADAMTS5 mRNA CTD PMID:26655953 inulin multiple interactions ISO Adamts5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTS5 mRNA CTD PMID:36331819 L-proline betaine multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 stachydrine inhibits the reaction [IL1B protein results in increased secretion of ADAMTS5 protein] CTD PMID:32417162 lead(0) affects expression ISO ADAMTS5 (Homo sapiens) 6480464 Lead affects the expression of ADAMTS5 mRNA CTD PMID:28903495 Licochalcone B decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 licochalcone B results in decreased expression of ADAMTS5 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 ITCH protein inhibits the reaction [Lipopolysaccharides results in increased expression of ADAMTS5 protein] and JAG1 protein inhibits the reaction [ITCH protein inhibits the reaction [Lipopolysaccharides results in increased expression of ADAMTS5 protein]] CTD PMID:35385713 lipopolysaccharide increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of ADAMTS5 protein CTD PMID:35385713 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of ADAMTS5 mRNA CTD PMID:28801915 methotrexate affects expression ISO Adamts5 (Mus musculus) 6480464 Methotrexate affects the expression of ADAMTS5 mRNA CTD PMID:18502557 mono(2-ethylhexyl) phthalate multiple interactions ISO Adamts5 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ADAMTS5 mRNA CTD PMID:36189433 nickel atom increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Nickel results in increased expression of ADAMTS5 mRNA CTD PMID:24768652 and PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ADAMTS5 mRNA CTD PMID:25729387 paclitaxel multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of ADAMTS5 mRNA CTD PMID:20705681 paracetamol decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ADAMTS5 mRNA CTD PMID:21420995 parathion increases methylation ISO ADAMTS5 (Homo sapiens) 6480464 Parathion results in increased methylation of ADAMTS5 promoter CTD PMID:22847954 perfluorooctane-1-sulfonic acid multiple interactions ISO Adamts5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTS5 mRNA CTD PMID:36331819 phenobarbital affects expression ISO Adamts5 (Mus musculus) 6480464 Phenobarbital affects the expression of ADAMTS5 mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS5 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ADAMTS5 mRNA CTD PMID:22079256 potassium chromate increases expression ISO ADAMTS5 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of ADAMTS5 mRNA CTD PMID:22714537 potassium chromate multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ADAMTS5 mRNA CTD PMID:22079256 rotenone increases expression ISO Adamts5 (Mus musculus) 6480464 Rotenone results in increased expression of ADAMTS5 mRNA CTD PMID:32937126 SB 431542 multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADAMTS5 mRNA CTD PMID:27188386 selenium atom decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Selenium results in decreased expression of ADAMTS5 mRNA CTD PMID:19244175 serpentine asbestos increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of ADAMTS5 mRNA CTD PMID:24160326 silicon dioxide decreases expression ISO Adamts5 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of ADAMTS5 mRNA CTD PMID:23221170 sodium arsenite decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of ADAMTS5 mRNA CTD PMID:25493608 succimer multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS5 mRNA CTD PMID:26378955 sulforaphane decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 sulforaphane results in decreased expression of ADAMTS5 mRNA CTD PMID:31838189 T-2 toxin increases expression ISO ADAMTS5 (Homo sapiens) 6480464 T-2 Toxin results in increased expression of ADAMTS5 mRNA CTD PMID:18196609 T-2 toxin increases expression ISO Adamts5 (Mus musculus) 6480464 T-2 Toxin results in increased expression of ADAMTS5 mRNA CTD PMID:22800716 terbufos increases methylation ISO ADAMTS5 (Homo sapiens) 6480464 terbufos results in increased methylation of ADAMTS5 promoter CTD PMID:22847954 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADAMTS5 mRNA CTD PMID:32741896 tetrachloromethane increases expression ISO Adamts5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of ADAMTS5 mRNA CTD PMID:17484886 and PMID:29987408 tetrachloromethane multiple interactions ISO Adamts5 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ADAMTS5 mRNA CTD PMID:30517762 Theaflavin 3,3'-digallate multiple interactions EXP 6480464 theaflavin-3 more ... CTD PMID:35847580 titanium dioxide multiple interactions ISO Adamts5 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS5 mRNA CTD PMID:29950665 titanium dioxide decreases expression ISO Adamts5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of ADAMTS5 mRNA CTD PMID:23557971 and PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ADAMTS5 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ADAMTS5 mRNA CTD PMID:25729387 trans-2-Phenylcyclopropanecarboxylic acid multiple interactions ISO ADAMTS5 (Homo sapiens) 6480464 2-phenylcyclopropanecarboxylic acid analog binds to and results in decreased activity of ADAMTS5 protein CTD PMID:21417219 trichostatin A increases expression ISO ADAMTS5 (Homo sapiens) 6480464 trichostatin A results in increased expression of ADAMTS5 mRNA CTD PMID:24935251 valproic acid decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ADAMTS5 mRNA CTD PMID:23179753 valproic acid affects expression ISO ADAMTS5 (Homo sapiens) 6480464 Valproic Acid affects the expression of ADAMTS5 mRNA CTD PMID:25979313 valproic acid increases expression ISO ADAMTS5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ADAMTS5 mRNA CTD PMID:24935251 and PMID:28001369 vitamin E decreases expression ISO ADAMTS5 (Homo sapiens) 6480464 Vitamin E results in decreased expression of ADAMTS5 mRNA CTD PMID:19244175 vorinostat increases expression ISO ADAMTS5 (Homo sapiens) 6480464 vorinostat results in increased expression of ADAMTS5 mRNA CTD PMID:26272509